Minimally Invasive Metastasectomy in Canines (MIMIC)
OpenCURRENTLY ENROLLING
The MIMIC clinical trial is open for enrollment. Ethos Discovery is investigating a new minimally-invasive surgical treatment for canine osteosarcoma that has metastasized, or spread, to the lungs. This study is subsidized and all procedures will be provided at an affordable, low cost.
Eligibility Criteria:
• Dogs weighing >5 kgs with a diagnosis of osteosarcoma
• Local tumor controlled or able to be controlled through surgery or radiation
• Suspected or confirmed cancer that has metastasized in the lungs
The Objective of This Study: The use of surgery to manage osteosarcoma in dogs has been shown to be promising, but is not commonly used due to the risks of conventional thoracic surgery. We seek to reduce risks and improve
outcomes using minimally invasive surgical techniques. These trials will pave the way to conduct accelerated studies to identify new drugs to prevent lung metastases in both human and canine osteosarcoma.
What to Expect: A surgical technique using miniature incisions in the chest wall to allow removal of lung nodules with the assistance of a magnified video camera. This has the potential to minimize the pain, morbidity, and recovery
time to patients at a fraction of what’s observed with conventional techniques. We predict patients will be recovered within 2 days and able to begin returning to normal life.